Skip to main content

Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

Publication ,  Conference
Ko, YJ; Devi, GR; London, CA; Kayas, A; Reddy, MT; Iverson, PL; Bubley, GJ; Balk, SP
Published in: CLINICAL CANCER RESEARCH
December 1, 2003

Duke Scholars

Published In

CLINICAL CANCER RESEARCH

ISSN

1078-0432

Publication Date

December 1, 2003

Volume

9

Issue

16

Start / End Page

6084S / 6084S

Location

BOSTON, MASSACHUSETTS

Publisher

AMER ASSOC CANCER RESEARCH

Conference Name

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ko, Y. J., Devi, G. R., London, C. A., Kayas, A., Reddy, M. T., Iverson, P. L., … Balk, S. P. (2003). Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. In CLINICAL CANCER RESEARCH (Vol. 9, pp. 6084S-6084S). BOSTON, MASSACHUSETTS: AMER ASSOC CANCER RESEARCH.
Ko, Y. J., G. R. Devi, C. A. London, A. Kayas, M. T. Reddy, P. L. Iverson, G. J. Bubley, and S. P. Balk. “Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.” In CLINICAL CANCER RESEARCH, 9:6084S-6084S. AMER ASSOC CANCER RESEARCH, 2003.
Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iverson PL, et al. Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. In: CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2003. p. 6084S-6084S.
Ko, Y. J., et al. “Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.CLINICAL CANCER RESEARCH, vol. 9, no. 16, AMER ASSOC CANCER RESEARCH, 2003, pp. 6084S-6084S.
Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iverson PL, Bubley GJ, Balk SP. Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2003. p. 6084S-6084S.

Published In

CLINICAL CANCER RESEARCH

ISSN

1078-0432

Publication Date

December 1, 2003

Volume

9

Issue

16

Start / End Page

6084S / 6084S

Location

BOSTON, MASSACHUSETTS

Publisher

AMER ASSOC CANCER RESEARCH

Conference Name

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis